DOI: 10.1161/jaha.126.049304 ISSN: 2047-9980

Impact of Balloon‐Expandable Valve Asymmetry on Heart Failure Post Transcatheter Aortic Valve Replacement

Shinnosuke Kikuchi, Antonin Trimaille, Adrien Carmona, Amandine Granier, Marion Kibler, Dinh Phi Truong, Kensuke Matsushita, Benjamin Marchandot, Manh Cuong Vu, Franck Zheng, Zoe Heyberger, Julien Tse Sik Sun, Florian Loizon, Paul Knellwolf, Dorian Recht, Baudouin Koenig, Mickael Ohana, Kiyoshi Hibi, Patrick Ohlmann, Olivier Morel
Show PDF Cite

Background

Fluoroscopic assessment enables immediate evaluation of transcatheter heart valve expansion during transcatheter aortic valve replacement (TAVR). Whether fluoroscopic asymmetric expansion of balloon‐expandable valves is associated with post‐TAVR heart failure (HF) remains uncertain.

Methods

Among 607 consecutive patients undergoing balloon‐expandable valve‐TAVR in a prospective registry, 589 were analyzed. Valve asymmetry was quantified using a fluoroscopic asymmetry index (%), defined as [(longest/shortest balloon‐expandable valve height)−1]×100. The primary end point was 2‐year HF hospitalization.

Results

During follow‐up, 99 patients (17%) experienced HF hospitalization. As a continuous variable, asymmetry index (%) was not independently associated with 2‐year HF (adjusted hazard ratio [HR] per 1% increase, 1.02 [95% CI, 0.98–1.06]). Restricted cubic spline analysis demonstrated no significant linear or nonlinear association (overall P =0.71; P for nonlinearity=0.89), although the risk curve suggested increased HF risk beyond moderate valve asymmetry. Exploratory threshold analysis identified an asymmetry index cutoff of 7.48%. Patients above this threshold had a higher incidence of HF hospitalization than those below it (23.6% versus 15.8%; log‐rank P =0.043), despite comparable rates of impaired valve performance at discharge. Valve asymmetry >7.48% remained independently associated with late HF occurring beyond 30 days after TAVR (adjusted HR, 1.69 [95% CI, 1.10–2.60]).

Conclusions

Fluoroscopic assessment of balloon‐expandable valve expansion identified patients with marked valve asymmetry at increased risk of late HF after TAVR, despite preserved early valve performance. These findings support the potential value of intraprocedural valve geometry assessment for long‐term risk stratification and warrant further investigation.

More from our Archive